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Abstract Aim: To determine the
incidence of late intracranial vita-
min K deﬁciency bleeding (VKDB)
in The Netherlands using the Dutch
Pediatric Intensive Care Evaluation
(PICE) registry. Methods: The
PICE registry was used to identify all
infants who were admitted to a Dutch
pediatric intensive care unit (PICU)
with intracranial bleeding between 1
January 2004 and 31 December 2007.
Cases of conﬁrmed late intracranial
VKDB were used to calculate the
incidence for each year. To estimate
the completeness of ascertainment of
the PICE registry, data from 2005
were compared with general surveil-
lance data from that year.
Results: In the 4-year study period,
16/64 (25%) of the infants admitted
with intracranial bleeding had late
intracranial VKDB, resulting in an
overall incidence of 2.1/100,000 live
births (95% conﬁdence interval
1.2–3.5). The single-year incidence
varied markedly between 0.5 and 3.3
per 100,000 live births. All ﬁve
ascertained cases in 2005 were iden-
tiﬁed using the PICE registry, while
general surveillance identiﬁed only
three. Conclusions: The PICE reg-
istry allows ongoing monitoring of
the incidence of late intracranial
VKDB and appears to be associated
with a higher rate of completeness
than general surveillance. We pro-
pose the use of pediatric intensive
care registries to assess the efﬁcacy of
national vitamin K prophylactic
regimens.
Keywords Vitamin K deﬁciency  
Intracranial bleeding   Prophylaxis  
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Introduction
Intracranial hemorrhage is a frequent manifestation of
vitamin Kdeﬁciency(VKD)ininfancy.Itisthepresenting
symptom in approximately 50% of cases with late vita-
min K deﬁciency bleeding (VKDB) in Western Europe,
with even higher rates (up to 82%) reported in developing
countries [1–10]. As such intracranial bleeding is associ-
ated with a high mortality rate and serious neurological
sequelae [1, 3–6, 11–13], preventing it is a major objective
of national vitamin K prophylactic regimens worldwide.
Thus far, the efﬁcacy of vitamin K prophylactic reg-
imens is evaluated on the basis of the incidence of VKDB
under a given regimen. The incidence is calculated from
the number of ascertained cases from general surveillance
studies. However, as illustrated by two surveillance
studies from The Netherlands, these data should be
interpreted with caution. Both a low incidence of 1.1/
100,000 (in 1992–1994) and a relatively high incidence of
3.2/100,000 (in 2005) were reported using this method-
ology under a single prophylactic regimen [3, 14]. These
data underline that the incidence is not merely a reﬂection
Intensive Care Med (2011) 37:1014–1020
DOI 10.1007/s00134-011-2175-7 PEDIATRIC ORIGINALof the efﬁcacy of a prophylactic regimen. Random vari-
ations in factors strongly associated with VKDB—
particularly the rate of breastfeeding and the incidence of
cholestasis—may have a signiﬁcant impact on the inci-
dence. In addition, the degree of completeness of
ascertainment may play a pivotal role. Particularly, a low
degree of completeness will cause underestimation of the
incidence of late VKDB and hence false reassurance
regarding the effectiveness of prophylaxis.
Alternative approaches may overcome the drawbacks
of general surveillance. We previously showed that reg-
istries for cholestatic liver diseases can be used to
determine the protection offered to high-risk infants [9,
15]. Here, based on the observation that infants with late
intracranial VKDB are routinely admitted to a pediatric
intensive care unit (PICU), we investigated whether a
pediatric intensive care registry can be used to more
reliably determine the incidence of late intracranial
VKDB. Retrieving cases of late intracranial VKDB from
the Dutch pediatric intensive care registry over a 4-year
timeframe not only allowed a view on the year-to-year
variation of late intracranial VKDB, but also allowed us
to compare its completeness with general surveillance.
Methods
Patients
The diagnoses of all infants admitted to the eight Dutch
PICUs are registered in the National Pediatric Intensive
Care Evaluation (PICE) registry from 2003 onwards. The
PICE registry was used to identify infants between the age
of 8 days and 6 months, who were admitted to a Dutch
PICU with intracranial bleeding between 1 January 2004
and 31 December 2007. To minimize the risk of missing
infants with late intracranial VKDB, the search strategy
was designed to allow detection through the diagnosis
intracranial bleeding, through the symptoms of intracra-
nial bleeding, and through the underlying disorder. Search
items were: brain dead, cerebral infarct or stroke,
intracranial hemorrhage, convulsions, meningitis, gastro-
intestinal bleeding, hepatitis, other liver diseases, biliary
atresia, neonatal jaundice, other gastrointestinal diseases,
and coagulation defects. Of the infants who were admitted
to a PICU with intracranial bleeding, discharge letters and
laboratory data were studied to determine the causes of
the intracranial bleeding. Patient ﬁles of infants suspected
of intracranial VKDB were reviewed to establish whether
VKD was present and to obtain relevant clinical
characteristics.
Approval for the study was obtained from the Uni-
versity Medical Center Utrecht Ethics Committee.
Late intracranial VKDB
Late intracranial VKDB was deﬁned as intracranial
bleeding (conﬁrmed using computer tomography or mag-
netic resonance imaging) in the presence of prothrombin
ratio (PR) C4 which normalized after administration of
vitamin K, in an infant between the age of 8 days and
6 months[8,9].Ifdetermined,theinternationalnormalized
ratio(INR)wasusedasPR.Ifonlyaprothrombintime(PT)
in seconds was available, the PR was calculated with the
formula: PR = PTpatient/PTcontrol.I fP T control was not
determined, the mean of the provided reference rate was
used as PTcontrol [9]. If available, the concentration of
proteinsinducedbyvitamin Kabsence(PIVKAs)hadtobe
above the reference value of the used assay [8].
Clinical characteristics
Of the infants with late intracranial VKDB, the values of
several biochemical parameters and the age and weight at
diagnosis were obtained, as well as information con-
cerning the severity, outcome, and etiology of the
bleeding. Age at diagnosis was deﬁned as the age of the
infant when ﬁrst seen by a doctor with complaints related
to VKD. Cholestasis was deﬁned as total serum bilirubin
concentration[50 lmol/l with direct fraction C20% [9].
When administration of vitamin K prophylaxis to an
infant was mentioned in the patient ﬁle but the quantity of
vitamin K was not speciﬁed, it was assumed that the
Dutch vitamin K prophylactic regimen was followed,
consisting of administration of 1 mg vitamin K orally
directly after birth followed by daily administration of
25 lg vitamin K orally from 1 week to 3 months post
partum [16]. According to the absence or presence of an
underlying disorder predisposing to VKD, late intracra-
nial VKDB was subclassiﬁed as idiopathic late
intracranial VKDB or secondary late intracranial VKDB,
respectively [8].
Statistical analysis
To determine the overall incidence of late intracranial
VKDB and to assess completeness of ascertainment of
late intracranial VKDB, a capture–recapture analysis was
performed on the patients captured in 2005 by the PICE
registry and general surveillance [3]. Birth date, gender,
and initials from patients captured by the PICE registry
were retrieved from local databases and were used to
identify the infants detected in both studies. The total
number of infants with late intracranial VKDB in 2005
was calculated with the formula [17]
1015N ¼
ðn1 þ 1Þðn2 þ 1Þ
ðn12 þ 1Þ
  1:
In this formula N is the estimated total number of infants
with late intracranial VKDB, n1 is the number of infants
with late intracranial VKDB detected with the PICE
registry, n2 is the number of infants with late intracranial
VKDB detected with general surveillance, and n12 is the
number of infants with late intracranial VKDB who were
detected in both studies. The 95% conﬁdence interval
was calculated with the formula [18]
N   1:96
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðn1 þ 1Þðn2 þ 1Þðn1   n12Þðn2   n12Þ
ðn12 þ 1Þ
2ðn12 þ 2Þ
s
:
The total number of infants with late intracranial VKDB
in 2005 was used to determine the incidence of late
intracranial VKDB in that year. The 95% conﬁdence
interval of the incidence was calculated according to a
Poisson distribution. Completeness of a surveillance
strategy was deﬁned as the percentage of the calculated
total of infants with late intracranial VKDB retrieved by
the respective strategy.
Results
Intracranial bleeding
Between 1 January 2004 and 31 December 2007, 18,233
infants were admitted to the Dutch PICUs. The search
strategy retrieved 428 infants, 64 of whom were diag-
nosed with intracranial bleeding (Table 1). Child abuse
was the proven (5 patients) or highly suspected (12
patients) cause of intracranial bleeding in 17 patients.
Sixteen infants had conﬁrmed late intracranial VKDB
(Table 2). In one additional infant, late intracranial
VKDB was suspected, but could not be conﬁrmed,
because vitamin K was already supplemented before the
coagulation factors were measured and no PIVKA
analysis was performed. Mean age at presentation in
patients with late intracranial VKDB was signiﬁcantly
lower than in patients with intracranial bleeding due to
child abuse (47 versus 90 days, p = 0.01) (Fig. 1). As a
consequence, VKD was the most common cause of
intracranial bleeding in the ﬁrst 3 months of life (14/41,
34%).
Late intracranial VKDB
Of the 16 infants with conﬁrmed late intracranial VKDB,
12 were boys (75%). Mean age at diagnosis was 47 days
(Table 3). In eight infants (50%) so-called warning bleeds
(e.g., hematemesis, nasal bleeding, and ecchymoses) were
seen before symptoms consistent with late intracranial
VKDB occurred. The most common locations of the
intracranial VKDB were subdural (8/16, 50%) and intra-
cerebral (6/16, 38%). Eleven infants (69%) required
mechanical ventilation. Seven infants (44%) underwent
neurosurgical intervention. In three additional infants
Table 1 Incidence of intracranial bleeding and late intracranial VKDB in The Netherlands calculated by using the PICE registry
2004 2005 2006 2007 2004–2007
Live births (N) 194,007 187,910 185,057 181,336 748,310
Patients admitted to a PICU (N) 4,532 4,663 4,612 4,426 18,233
Intracranial bleeding (N) 18 21 9 16 64
Incidence of intracranial bleeding
(95% CI)
a 9.3/100,000
(5.5–14.7)
11.2/100,000
(6.9–17.1)
4.9/100,000
(2.2–9.2)
8.8/100,000
(5.0–14.3)
8.6/100,000
(6.6–11.0)
Late intracranial VKDB (N)4 5 1 6 1 6
Incidence of late intracranial VKDB
(95% CI)
a 2.1/100,000
(0.6–5.3)
2.7/100,000
(0.9–6.2)
0.5/100,000
(0.0–3.0)
3.3/100,000
(1.2–7.2)
2.1/100,000
(1.2–3.5)
VKDB vitamin K deﬁciency bleeding, PICE pediatric intensive care evaluation, N number, PICU pediatric intensive care unit, 95% CI
95% conﬁdence interval
a Incidence calculated per 100,000 live births
Table 2 Causes of intracranial bleeding in infants between the age
of 8 days and 6 months admitted to a Dutch PICU between 2004
and 2007
Cause Number Percentage
(%)
Child abuse 17 26.6
Vitamin K deﬁciency 17 26.6
Conﬁrmed 16 25.0
Suspected 1 1.6
Accidental head trauma 10 15.6
Other coagulation disorders 6 9.4
Congenital cardiovascular abnormality 4 6.3
Iatrogenous 3 4.7
Vascular malformation 2 3.1
Intraventricular bleeding due to prematurity 2 3.1
Unknown 2 3.1
Tumor 1 1.6
Total 64 100
PICU pediatric intensive care unit
1016(19%), a neurosurgical intervention was considered but
could not be performed because of the poor condition of
the infant. In total, six patients died as a consequence of
intracranial bleeding (38%) and six infants had severe
neurological sequelae after a follow-up period of
6 months (38%).
Fourteen of the 16 infants had secondary late intra-
cranial VKDB (88%), of which 13 were due to cholestasis
(81%) (Table 4). Although no disorder predisposing to
VKD could be established in two cases, abnormalities
consistent with fat malabsorption were present in both
patients. One infant had elevated serum bile acids
(22 lmol/l), indicative of cholestasis. The other infant
had diminished values of cholesterol and triglycerides
(1.0 and \0.1 mmol/l, respectively). Cystic ﬁbrosis was
considered but excluded in this patient. Fourteen infants
were fully breastfed (88%). At least 10/14 (71%) had
received the recommended vitamin K prophylaxis. In two
infants the degree of adherence could not be retrieved. In
the two additional infants adherence to prophylaxis was
suboptimal; one infant did not receive the 1 mg vita-
min K on the ﬁrst day post partum, and the other infant
only received 25 lg vitamin K weekly after the 1 mg
vitamin K post partum.
Incidence of late intracranial VKDB
Between 2004 and 2007 the annual incidence of late
intracranial VKDB varied from 0.5 per 100,000 live
births (95% CI: 0.0–3.0) to 3.3 per 100,000 live births
(95% CI: 1.2–7.2) (Table 1). The average incidence of
late intracranial VKDB over 2004–2007 was 2.1 per
100,000 live births (95% CI: 1.2–3.5).
Completeness of ascertainment
To evaluate completeness we compared the cases of late
intracranial VKDB in 2005 identiﬁed using the PICE
registry with those identiﬁed using general surveillance.
Five infants with late intracranial VKDB were identiﬁed
by the PICE registry, compared with three infants (out of
six with VKDB) identiﬁed through general surveillance
[3]. As the latter infants were also identiﬁed by the PICE
registry, the estimated total number of infants with late
intracranial VKDB in 2005 was ﬁve. The characteristics
and severity of the two cases missed using general sur-
veillance did not differ from the characteristics and
severity of the other three cases.
Discussion
This is the ﬁrst study to demonstrate that a pediatric
intensive care registry is a novel instrument to determine
the incidence of late intracranial VKDB. This strategy
allows long-term monitoring of late intracranial VKDB
and results in a higher degree of completeness than gen-
eral surveillance studies. Furthermore these data show
that VKD—a preventable disease—is the most frequent
cause of intracranial bleeding in the ﬁrst 3 months of life
in infants admitted to Dutch pediatric intensive care units.
Fig. 1 Comparison of mean age at presentation in patients with
intracranial bleeding due to vitamin K deﬁciency, child abuse, and
accidental head trauma. VKDB vitamin K deﬁciency bleeding
Table 3 Characteristics of infants with conﬁrmed late intracranial
VKDB admitted to a Dutch PICU between 2004 and 2007
Feature
Male/female, N (%) 12 (75)/4 (25)
Birth weight, mean (range), g 3,339 (2,160–4,010)
Age at diagnosis, mean (range), days 47 (19–129)
Weight at diagnosis, mean (range), g 4,178 (3,200–5,240)
Biochemical parameters
Bilirubin total, median (range), lmol/l 82 (8–226)
Bilirubin direct, median (range), lmol/l 52 (5–134)
ASAT, median (range), U/l 92 (33–773)
ALAT, median (range), U/l 48 (20–869)
Etiology
Cholestasis, N (%) 13 (81)
Underlying disorder, N (%) 14 (88)
Breastfeeding, N (%) 14 (88)
Severity of bleeding
Mechanical ventilation, N (%) 11 (69)
Neurosurgical intervention, N (%) 7 (44)
No neurosurgical intervention due to poor
condition, N (%)
3 (19)
Outcome
Died, N (%) 6 (38)
Neurological sequelae, N (%) 6 (38)
VKDB vitamin K deﬁciency bleeding, PICU pediatric intensive
care unit, N number, ASAT asparagine aminotransferase, ALAT
alanine aminotransferase
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1018Previously, Danielson et al. [19] identiﬁed patients
with late intracranial VKDB by retrieving patient ﬁles of
intracranial hemorrhages. Applying this approach to the
pediatric intensive care registry provided a dataset with
the same nationwide coverage as that obtained using
general surveillance, a prerequisite for performing cap-
ture–recapture analysis. This analysis—for the ﬁrst
time—allowed a view on the (lack of) completeness of
general surveillance. In the year of comparison between
the two methods, two out of ﬁve cases of late intracranial
VKDB would have been missed using general surveil-
lance only. Furthermore, the PICE registry data allowed
us to delineate the substantial year-to-year variation in the
incidence of late intracranial VKDB (a factor of 6
between the highest and lowest year incidence), con-
ﬁrming our suspicion that single-year surveillance may
lead to erroneous conclusions. Had general surveillance
been performed in 2006, the incidence of late intracranial
VKDB would have been *5 times lower than that in
2005. Finally, the data on the relative frequency of late
intracranial VKDB as compared with other causes of
intracranial bleeding in infancy provided a meaningful
context, putting the incidence ﬁgures (2.1/100,000) in
perspective.
There are some limitations of this study. First,
although completeness was higher than from general
surveillance and despite all efforts to minimize this, the
registry can occasionally be incomplete. In addition, cases
will be missed if late intracranial VKDB causes death
before admittance to a PICU or if PICU admittance is
unnecessary in case of mild late intracranial VKDB. As a
consequence, the real incidence of late intracranial VKDB
is likely even higher than reported here. Furthermore, it
should not be forgotten that an unknown number of cases
of VKDB will inevitably be unnoticed because bleeding
occurred at another site.
Pediatric intensive care registries are operational in
various countries, including the USA (Virtual Pediatric
Intensive Care Unit Performance System) and the UK
(Paediatric Intensive Care Audit Network), to compare
and improve the quality of care of PICUs [20]. This study
exempliﬁes that these registries can also be used for
epidemiological studies on (rare) diseases which neces-
sitate intensive care treatment, including late intracranial
VKDB. Moreover, we believe that pediatric intensive care
registries can be used to compare the efﬁcacies of
different vitamin K prophylactic regimens and to opti-
mize vitamin K prophylactic regimens.
Our data conﬁrm that most (if not all) infants with late
intracranial VKDB under the current vitamin K prophy-
laxis had evidence of fat malabsorption at the time of
diagnosis, mostly cholestasis [3]. Notably, biliary atresia
accounted for only 19% of all cases with late intracranial
VKDB, much less than the 66% observed from recent
general surveillance data [3]. Most other causes of cho-
lestasis observed in this study were of more transient
nature. Despite aggressive intervention, late intracranial
VKDB is associated with a high rate of mortality and
neurological sequelae, similar to previous reports [1, 4–6,
11, 12, 21]. The importance of recognizing the prime
warning signs for late intracranial VKDB in infants (both
cholestatic jaundice and seemingly harmless bleeds, e.g.,
hematemesis, nasal bleeding, and ecchymoses) cannot be
stressed enough. However, recent data demonstrate that
increased awareness of these signs alone is not sufﬁcient
to prevent VKDB [15]. Only an adequate speciﬁc vita-
min K dosing regimen is capable of preventing such
bleeding in virtually all infants [9, 22].
Our data underline the conclusions from general sur-
veillance and from at-risk populations that the current
Dutch vitamin K prophylaxis is inadequate [3, 9]. The
high frequency of late intracranial VKDB in infants and
the severity of the intracranial VKDB reported here
underscore the need to change the current regimen.
In conclusion, this study provides proof of principle
for the use of national PICU registries for ongoing, high-
quality monitoring of the incidence of late intracranial
vitamin K deﬁciency bleeding. In our opinion, PICU
registries may provide a valuable instrument to evaluate
the efﬁcacy of vitamin K prophylactic regimens.
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